News

The Pregnabit system is being tested by one of the hospitals in Sofia. You can learn about the development goals of Maychin Dom hospital, including about its plans for the implementation of telemedical devices from the head of the maternity ward and the Mayor of Sofia invited by the hospital. This is the place where our solution undergoes pilot implementation now. We encourage you to watch a video included in the publication under the link below. Although it is in Bulgarian, you will certainly guess what it is all about, especially if you check 00:26 and 01:00 of the video.

(more…)

We have received another tranche of funds from a German investor. This is an effect of the agreement signed on 10 July with a German fund, Deutsche Balaton AG. The funds obtained will be used to introduce our solution: Pregnabit teleCTG to new foreign markets.

“We have great faith in Nestmedic and its product. In our opinion, it fills a gap in the medical sector on many markets. We hope to connect well with the Nestmedic team and be globally successful together,” said Armin Burckhardt, Equity Manager, Deutsche Balaton AG.

The transaction between Nestmedic S.A. and Deutsche Balaton AG concerned the issue of bonds convertible into series A shares under a private placement arrangement. All 28,571 series A bonds at the price of 150 PLN per one series A bond have been offered to Deutsche Balaton AG as a shareholder. The transaction amounted to the total of 4,282,560 PLN.

“We are very happy to close another stage of our cooperation with Deutsche Balaton AG. The transaction is a tangible proof that the Company and its market prospects are something to be trusted and confided in. The financing is the source of stability and the opportunity to focus more strongly on the actual business expansion. We also want to use the international experience and contacts of Deutsche Balaton AG,” emphasizes Konrad Kowalczuk, Member of the Management Board of Nestmedic S.A.

Nestmedic S.A. has found itself among 10 technology companies that were invited by Roche Polska and Startup Poland to an awareness-building meeting devoted to the potential and benefits associated with cooperation of global corporations with start-ups.

The meeting was held on 11 September in Warsaw, and our company was represented by CEO, Patrycja Wizińska-Socha. The event provided a unique opportunity to present our telemedical CTG solution – Pregnabit to the Management Board members and representatives of individual departments of Roche Polska and Roche.

“Roche Startup Day was a great opportunity to exchange knowledge and experience with representatives of the companies that are active in the dynamically developing digital health sector. Indeed, our business segment is of great interest for global corporations from the medical and laboratory equipment and pharmaceutical market, as they are naturally prone to look for new directions to develop. Certainly, telemedical solutions are about new quality and huge potential, and this potential is noticed and recognised. Since the very beginnings of Nestmedic on the market, we have been focused on planning global commercialisation and scalability of our product. Therefore, talks with the representatives of Roche and the originators of other start-ups are so important to us. In addition, Roche Startup Day was a perfect platform for networking and knowledge sharing in the area of distribution and certification of medical devices, as well as the upcoming regulatory changes regarding the digitisation of medicine in Europe and the US,” says Patrycja Wizińska-Socha.